These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38795584)

  • 1. Biomimetic platelet-like nanoparticles enhance targeted hepatocellular carcinoma therapy.
    Wu Y; Fan Q; Zhou J; Hu H; Liao Z; Tang X; Xu M; Yang S; Lai J; Wan S; Wu J
    Colloids Surf B Biointerfaces; 2024 Aug; 240():113973. PubMed ID: 38795584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homotypic cell membrane-camouflaged biomimetic PLGA nanoparticle loading triptolide for the treatment of hepatocellular carcinoma.
    Li Z; Lan J; Wu Y; Ding Y; Zhang T
    Drug Deliv; 2024 Dec; 31(1):2354687. PubMed ID: 38823413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery.
    Wang H; Wu J; Williams GR; Fan Q; Niu S; Wu J; Xie X; Zhu LM
    J Nanobiotechnology; 2019 May; 17(1):60. PubMed ID: 31084622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, Characterization And Evaluation Of Curcumin- Loaded PLGA- TPGS Nanoparticles For Liver Cancer Treatment.
    Chen XP; Li Y; Zhang Y; Li GW
    Drug Des Devel Ther; 2019; 13():3569-3578. PubMed ID: 31802845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
    Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
    AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
    Vakilinezhad MA; Amini A; Dara T; Alipour S
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Chinese Angelica Polysaccharide Biomimetic Nanomedicine to Curcumin Delivery for Hepatocellular Carcinoma Treatment and Immunomodulatory Effect.
    Guo C; Hou X; Liu Y; Zhang Y; Xu H; Zhao F; Chen D
    Phytomedicine; 2021 Jan; 80():153356. PubMed ID: 33039729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles.
    Bian Y; Guo D
    Drug Des Devel Ther; 2020; 14():647-659. PubMed ID: 32109990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lenvatinib and Cu
    Xu Q; Li Q; Yang Z; Huang P; Hu H; Mo Z; Qin Z; Xu Z; Chen T; Yang S
    J Mater Chem B; 2021 Dec; 9(48):9908-9922. PubMed ID: 34842266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma.
    Xu L; Wu S; Zhou X
    J Biomater Appl; 2018 Jul; 33(1):72-81. PubMed ID: 29699442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of surface modification of As
    Song X; You J; Shao H; Yan C
    Colloids Surf B Biointerfaces; 2018 Sep; 169():289-297. PubMed ID: 29793091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
    Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma.
    Li Z; Yang G; Han L; Wang R; Gong C; Yuan Y
    J Nanobiotechnology; 2021 Nov; 19(1):360. PubMed ID: 34749742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma.
    Guo L; Li H; Fan T; Ma Y; Wang L
    Life Sci; 2021 Aug; 279():119359. PubMed ID: 33753114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homotypic Cell Membrane-Cloaked Biomimetic Nanocarrier for the Targeted Chemotherapy of Hepatocellular Carcinoma.
    Liu X; Sun Y; Xu S; Gao X; Kong F; Xu K; Tang B
    Theranostics; 2019; 9(20):5828-5838. PubMed ID: 31534522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.